|
CMPK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62747593179802E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.25295346215171E-14 |
| Normal-vs-Stage2 |
1.53040000006044E-07 |
| Normal-vs-Stage3 |
1.63509983330812E-10 |
| Normal-vs-Stage4 |
8.47177883400718E-12 |
| Stage1-vs-Stage2 |
8.266600E-01 |
| Stage1-vs-Stage3 |
6.362400E-01 |
| Stage1-vs-Stage4 |
1.016800E-01 |
| Stage2-vs-Stage3 |
9.151800E-01 |
| Stage2-vs-Stage4 |
3.241000E-01 |
| Stage3-vs-Stage4 |
2.552200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65423230669148E-14 |
| Normal-vs-AfricanAmerican |
1.553550E-04 |
| Normal-vs-Asian |
1.90319981996367E-10 |
| Caucasian-vs-AfricanAmerican |
3.170000E-01 |
| Caucasian-vs-Asian |
5.386400E-01 |
| AfricanAmerican-vs-Asian |
1.700750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.65210100944569E-11 |
| Normal-vs-Female |
1.63125069008174E-12 |
| Male-vs-Female |
4.537600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.44271311248212E-12 |
| Normal-vs-Age(41-60Yrs) |
7.8159700933611E-14 |
| Normal-vs-Age(61-80Yrs) |
1.87579951571593E-10 |
| Normal-vs-Age(81-100Yrs) |
1.079870E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.863400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.680400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.069600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.452200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.043400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.257200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.912600E-01 |
| Classical-VS-Follicular |
7.294800E-01 |
| Classical-VS-Other |
7.503800E-01 |
| Classical-VS-Normal |
1.69486646939276E-12 |
| Tall-VS-Follicular |
9.068600E-01 |
| Tall-VS-Other |
8.231200E-01 |
| Tall-VS-Normal |
1.92799999998439E-06 |
| Follicular-VS-Other |
8.917400E-01 |
| Follicular-VS-Normal |
3.15220000102201E-08 |
| Other-VS-Normal |
5.097300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.3677509365998E-13 |
| Normal-vs-N1 |
2.29061214440662E-12 |
| N0-vs-N1 |
9.805900E-02 |
|
|
